Researchers review current evidence on Candida auris, an emerging multidrug-resistant yeast

FHS
May 6, 2024
2:56 pm

Researchers discuss current evidence on Candida auris, an emerging multidrug-resistant yeast.

Combination of techniques reveals molecular changes in osteoarthritis

Osteoarthritis is the most common degenerative joint disease, affecting 22% of adults over 40 globally. Although the condition has been extensively studied through a medical

July 6, 2023

Maternal Covid-19 vaccination offers infants immunity for up to 6 months

The risks of severe neonatal morbidity, neonatal death, and admission to the neonatal intensive care unit were all significantly lower during the first month of

October 23, 2023

Mainz Biomed to Present at the Cantor Fitzgerald Global Healthcare Conference – Biotech Investments

Issuer: Mainz BioMed N.V. / Key word(s): Conference 20.09.2023 / 09:01 CET/CEST The issuer is solely responsible for the content of this announcement. Mainz Biomed

September 21, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.